Literature DB >> 26593885

Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe.

Aneta Ścieżyńska1, Dominika Oziębło2, Anna M Ambroziak3, Magdalena Korwin4, Kamil Szulborski4, Maciej Krawczyński5, Piotr Stawiński2, Jerzy Szaflik4, Jacek P Szaflik4, Rafał Płoski6, Monika Ołdak7.   

Abstract

Variation in the ABCA4 locus has emerged as the most prevalent cause of monogenic retinal diseases. The study aimed to discover causative ABCA4 mutations in a large but not previously investigated cohort with ABCA4-related diseases originating from Central Europe and to refine the genetic relevance of all identified variants based on population evidence. Comprehensive clinical studies were performed to identify patients with Stargardt disease (STGD, n = 76) and cone-rod dystrophy (CRD, n = 16). Next-generation sequencing targeting ABCA4 was applied for a widespread screening of the gene. The results were analyzed in the context of exome data from a corresponding population (n = 594) and other large genomic databases. Our data disprove the pathogenic status of p.V552I and provide more evidence against a causal role of four further ABCA4 variants as drivers of the phenotype under a recessive paradigm. The study identifies 12 novel potentially pathogenic mutations (four of them recurrent) and a novel complex allele p.[(R152*; V2050L)]. In one third (31/92) of our cohort we detected the p.[(L541P; A1038V)] complex allele, which represents an unusually high level of genetic homogeneity for ABCA4-related diseases. Causative ABCA4 mutations account for 79% of STGD and 31% of CRD cases. A combination of p.[(L541P; A1038V)] and/or a truncating ABCA4 mutation always resulted in an early disease onset. Identification of ABCA4 retinopathies provides a specific molecular diagnosis and justifies a prompt introduction of simple precautions that may slow disease progression. The comprehensive, population-specific study expands our knowledge on the genetic landscape of retinal diseases.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABCA4; Complex allele; Cone-rod dystrophy; Mutation; Next-generation sequencing; Stargardt disease

Mesh:

Substances:

Year:  2015        PMID: 26593885     DOI: 10.1016/j.exer.2015.11.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

Review 1.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

2.  Clinical and Genetic Spectrum of Stargardt Disease in Argentinean Patients.

Authors:  Marcela D Mena; Angélica A Moresco; Sofía H Vidal; Diana Aguilar-Cortes; María G Obregon; Adriana C Fandiño; Juan M Sendoya; Andrea S Llera; Osvaldo L Podhajcer
Journal:  Front Genet       Date:  2021-03-26       Impact factor: 4.599

3.  Genomic screening of ABCA4 and array CGH analysis underline the genetic variability of Greek patients with inherited retinal diseases.

Authors:  Maria Tsipi; Maria Tzetis; Konstantina Kosma; Marilita Moschos; Maria Braoudaki; Myrto Poulou; Emmanuel Kanavakis; Sofia Kitsiou-Tzeli
Journal:  Meta Gene       Date:  2016-02-16

4.  Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs.

Authors:  Heidi L Schulz; Felix Grassmann; Ulrich Kellner; Georg Spital; Klaus Rüther; Herbert Jägle; Karsten Hufendiek; Philipp Rating; Cord Huchzermeyer; Maria J Baier; Bernhard H F Weber; Heidi Stöhr
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

5.  Novel compound heterozygous mutations in ABCA4 in a Chinese pedigree with Stargardt disease.

Authors:  Jianping Zhang; Anhui Qi; Xi Wang; Hong Pan; Haiming Mo; Jiwei Huang; Honghui Li; Zhenwen Chen; Meirong Wei; Binbin Wang
Journal:  Mol Vis       Date:  2016-12-30       Impact factor: 2.367

6.  Correlating the Expression and Functional Activity of ABCA4 Disease Variants With the Phenotype of Patients With Stargardt Disease.

Authors:  Fabian Garces; Kailun Jiang; Laurie L Molday; Heidi Stöhr; Bernhard H Weber; Christopher J Lyons; David Maberley; Robert S Molday
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-05-01       Impact factor: 4.799

7.  Variants in the ABCA4 gene in a Brazilian population with Stargardt disease.

Authors:  Mariana Vallim Salles; Fabiana Louise Motta; Renan Martin; Rafael Filippelli-Silva; Elton Dias da Silva; Patricia Varela; Kárita Antunes Costa; John PeiWen Chiang; João Bosco Pesquero; Juliana-Maria Ferraz Sallum
Journal:  Mol Vis       Date:  2018-08-01       Impact factor: 2.367

8.  Expanding the Mutation Spectrum in ABCA4: Sixty Novel Disease Causing Variants and Their Associated Phenotype in a Large French Stargardt Cohort.

Authors:  Marco Nassisi; Saddek Mohand-Saïd; Claire-Marie Dhaenens; Fiona Boyard; Vanessa Démontant; Camille Andrieu; Aline Antonio; Christel Condroyer; Marine Foussard; Cécile Méjécase; Chiara Maria Eandi; José-Alain Sahel; Christina Zeitz; Isabelle Audo
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

9.  Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes.

Authors:  Anna M Tracewska; Beata Kocyła-Karczmarewicz; Agnieszka Rafalska; Joanna Murawska; Joanna Jakubaszko-Jabłónska; Małgorzata Rydzanicz; Piotr Stawiński; Elżbieta Ciara; Beata S Lipska-Ziętkiewicz; Muhammad Imran Khan; Frans P M Cremers; Rafał Płoski; Krystyna H Chrzanowska
Journal:  Mol Vis       Date:  2021-07-16       Impact factor: 2.367

10.  Simultaneous Expression of ABCA4 and GPR143 Mutations: A Complex Phenotypic Manifestation.

Authors:  Winston Lee; Kaspar Schuerch; Yajing Xie; Jana Zernant; Stephen H Tsang; Janet R Sparrow; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.